Channel News AsiaUPDATE 2-Merck diabetes drug Januvia meets heart safety targetReuters(Adds analyst comment). By Bill Berkrot. April 27 (Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a cloud of ...Merck Gains as Januvia Diabetes Drug Doesn't Add to Heart RiskBloombergMerck Announces the Trial Evaluating Cardiovascular Outcomes with Sitagliptin ...MarketWatchMerck: Januvia Heart Safety Trial Meets Primary EndpointRTT NewsChannel News Asiaall 12 news articles »
